Recurrence-Free Survival Outcomes Based on Novel Classification Combining Lymphovascular Invasion, Perineural Invasion, and T4 Status in Stage II–III Colon Cancer

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics. CA Cancer J Clin. 2021;71:7–33. doi:10.3322/caac.21654
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–1474. doi:10.1245/s10434-010-0985-4
   PubMed Web of Science ®Google Scholar
• McLeod HL, Murray GI. Tumour markers of prognosis in colorectal cancer. Br J Cancer. 1999;79(2):191–203. doi:10.1038/sj.bjc.6690033
   PubMed Web of Science ®Google Scholar
• Lyall MS, Dundas SR, Curran S, Murray GI. Profiling markers of prognosis in colorectal cancer. Clin Cancer Res. 2006;12:1184–1191. doi:10.1158/1078-0432.CCR-05-1864
   PubMed Web of Science ®Google Scholar
• Benson AB 3rd, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22:3408–3419. doi:10.1200/JCO.2004.05.063
   PubMed Web of Science ®Google Scholar
• Kumar A, Kennecke HF, Renouf DJ, et al. (2015) Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer. Cancer. 2015;121(121):527–534. doi:10.1002/cncr.29072
   PubMed Web of Science ®Google Scholar
• Artac M, Turhal NS, Kocer M, et al. Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study. Tumori. 2014;100(2):143–148. doi:10.1177/030089161410000205
   PubMed Web of Science ®Google Scholar
• Labianca R, Nordlinger B, Beretta GD, et al. Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;24(Suppl 6):vi64–vi72. doi:10.1093/annonc/mdt354
   Web of Science ®Google Scholar
• Benson AB 3rd, Venook AP, Cederquist L, et al. Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(3):370–398. doi:10.6004/jnccn.2017.0036
   PubMed Web of Science ®Google Scholar
• Weiss JM, Schumacher J, Allen GO, et al. Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data. Ann Surg Oncol. 2014;21(6):1781–1791. doi:10.1245/s10434-014-3631-8
   PubMed Web of Science ®Google Scholar
• Booth CM, Nanji S, Wei X, et al. Adjuvant chemotherapy for stage II colon cancer: practice patterns and effectiveness in the general population. Clin Oncol. 2017;29(1):e29–e38. doi:10.1016/j.clon.2016.09.001
   Web of Science ®Google Scholar
• Kim S, Huh JW, Lee WY, et al. Lymphovascular invasion, perineural invasion, and tumor budding are prognostic factors for stage I colon cancer recurrence. Int J Colorectal Dis. 2020;35(5):881–885. doi:10.1007/s00384-020-03548-4
   PubMed Web of Science ®Google Scholar
• Huh JW, Lee WY, Shin JK, et al. A novel histologic grading system based on lymphovascular invasion, perineural invasion, and tumor budding in colorectal cancer. J Cancer Res Clin Oncol. 2019;145(2):471–477. doi:10.1007/s00432-018-2804-4
   PubMed Web of Science ®Google Scholar
• Skancke M, Arnott SM, Amdur RL, Siegel RS, Obias VJ, Umapathi BA. Lymphovascular invasion and perineural invasion negatively impact overall survival for stage II adenocarcinoma of the colon. Dis Colon Rectum. 2019;62(2):181–188. doi:10.1097/DCR.0000000000001258
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang H, Gong H, Cao M, Zhang G, Wang Y. Clinical significance of perineural invasion in stages II and III colorectal cancer. Pathol Res Pract. 2019;211:839–844. doi:10.1016/j.prp.2015.09.001
   Web of Science ®Google Scholar
• Huh JW, Lee JH, Kim HR, Kim YJ. Prognostic significance of lymphovascular or perineural invasion in patients with locally advanced colorectal cancer. Am J Surg. 2013;206(5):758–763. doi:10.1016/j.amjsurg.2013.02.010
   PubMed Web of Science ®Google Scholar
• Babcock BD, Aljehani MA, Jabo B, et al. High-risk stage II colon cancer: not all risks are created equal. Ann Surg Oncol. 2018;25(7):1980–1985. doi:10.1245/s10434-018-6484-8
   PubMed Web of Science ®Google Scholar
• Lim SB, Yu CS, Jang SJ, Kim TW, Kim JH, Kim JC. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum. 2010;53:377–384. doi:10.1007/DCR.0b013e3181cf8ae5
   PubMed Web of Science ®Google Scholar
• Batsakis JG. Nerves and neurotropic carcinomas. Ann Otol Rhinol Laryngol. 1985;94:426–427.
   PubMed Web of Science ®Google Scholar
• Weiser MR. AJCC 8th edition: colorectal cancer. Ann Surg Oncol. 2018;25(6):1454–1455. doi:10.1245/s10434-018-6462-1
   PubMed Web of Science ®Google Scholar
• Akagi Y, Adachi Y, Ohchi T, Kinugasa T, Shirouzu K. Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1616 patients over 24 years. Anticancer Res. 2013;33:2965–2970.
   PubMed Web of Science ®Google Scholar
• Tsai HL, Cheng KI, Lu CY, et al. Prognostic significance of depth of invasion, vascular invasion and numbers of lymph node retrievals in combination for patients with stage II colorectal cancer undergoing radical resection. J Surg Oncol. 2008;97:383–387. doi:10.1002/jso.20942
   PubMed Web of Science ®Google Scholar
• Yuan H, Dong Q, Zheng B, Hu X, Xu JB, Tu S. Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis. Oncotarget. 2017;8:46565–46579. doi:10.18632/oncotarget.15425
   PubMedGoogle Scholar
• Liebig C, Ayala G, Wilks J, Berger DH, Albo D. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol. 2009;27:5131–5137. doi:10.1200/JCO.2009.22.4949
   PubMed Web of Science ®Google Scholar
• Al-Sukhni E, Attwood K, Gabriel EM, LeVea CM, Kanehira K, Nurkin SJ. Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: a retrospective cohort study. Int J Surg. 2017;37:42–49. doi:10.1016/j.ijsu.2016.08.528
   PubMed Web of Science ®Google Scholar
• Jobling P, Pundavela J, Oliveira SM, Roselli S, Walker MM, Hondermarck H. Nerve-cancer cell cross-talk: a novel promoter of tumor progression. Cancer Res. 2015;75:1777–1781. doi:10.1158/0008-5472.CAN-14-3180
   PubMed Web of Science ®Google Scholar
• Yun HR, Kim HC, Lee WY, Cho YB, Yun SH, Chun HK. The necessity of chemotherapy in T3N0M0 colon cancer without risk factors. Am J Surg. 2009;198:354–358. doi:10.1016/j.amjsurg.2008.09.027
   PubMed Web of Science ®Google Scholar